PharmaTher Holdings Ltd (TSE:PHRM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
PharmaTher Holdings Ltd. has secured a meeting with the FDA to address a complete response letter regarding its ketamine drug application, aiming to resolve minor deficiencies. The company is focused on meeting FDA guidelines to help alleviate the ongoing ketamine shortage in the U.S., where ketamine has been in short supply since 2018.
For further insights into TSE:PHRM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue